The controversial proposed deal with Purdue Pharma hints at better alternatives to for-profit pharmaceutical companies.

New documents show that Big Pharma isn’t the only culprit when it comes to getting people hooked on addictive drugs.

With a few breakout moments and a deft soundbite or two, the two senators stepped out of Elizabeth Warren's shadow.

Or are they just looking to cut a deal for the sake of cutting a deal?

The 2020 hopeful connected the dots between drug addiction and corporate greed, and "Trump country" took notice.

People are dying because they can't afford necessary medications, but drug manufacturers say they need high prices to fund future breakthroughs.

The House of Representatives' first oversight hearing of 2019 wasn't about Trump. It was about skyrocketing drug prices.

The industry's price-gouging economic model was engineered by Wall Street and its political enablers—and only Washington can fix it.

The rising star seemed destined to be a 2020 contender. But the populist wave and Trump resistance threaten to stall his ascent.

The fight for Prop 61 in California could be a watershed moment in American health care.